Biomedical cell product model for preclinical studies carried out on a large laboratory animal
Objective: to develop a model of a biomedical cell product that is consistent with the «homologous drug» strategy based on protocols for preparing the cell component and scaffold carrier for preclinical studies on a large laboratory animal (pig). Materials and methods. Biomedical cell products and...
Saved in:
Main Authors: | M. N. Egorikhina, D. Ya. Aleinik, Yu. P. Rubtsova, I. N. Charykova, A. A. Struchcov, A. A. Ezhevskaya, V. I. Zagrekov, L. N. Sosnina, E. V. Zagaynova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2020-04-01
|
Series: | Вестник трансплантологии и искусственных органов |
Subjects: | |
Online Access: | https://journal.transpl.ru/vtio/article/view/1155 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dose Selection in Preclinical Studies: Cross-Species Dose Conversion
by: E. V. Shekunova, et al.
Published: (2020-02-01) -
PRECLINICAL AND CLINICAL ASPECTS OF THE DEVELOPMENT OF BIOMEDICAL CELL PRODUCTS
by: A. V. Tikhomirova, et al.
Published: (2018-03-01) -
Preclinical Studies in the Pharmaceutical Development Cycle
by: M. N. Makarova
Published: (2024-07-01) -
BIOCOMPATIBLE AND MATRIX PROPERTIES OF POLYLACTIDE SCAFFOLDS
by: V. I. Sevastianov, et al.
Published: (2018-06-01) -
On formal local homology modules
by: M.H. Bijan-Zadeh
Published: (2015-06-01)